EUVIMEDEUVIMED entdecken
Crossref

Analytical Validation of a Clinical Grade Prognostic and Classification Artificial Intelligence Laboratory Test for Men with Prostate Cancer

Paul Gerrard, Jingbin Zhang, Rikiya Yamashita, Huei-Chung Huang, Sanghita Nag, Sokha Nhek, Joshua Kish, Adam Cole, Nathan Silberman, Trevor J. Royce, Tim Showalter

AI in Precision Oncology · 2024

DOI: 10.1089/aipo.2024.0004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AI in Precision Oncology, 2024. Verfasst von Paul Gerrard und 10 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This is the first study of which we are aware to describe the analytical validation (AV) of clinical grade artificial intelligence (AI) algorithms for a commercially available prostate cancer test performed on hematoxylin and eosin stained specimens that is not dependent on a priori established molecules or a priori semantically meaningful morphology.

Methods

We adapted AV methods used in molecular diagnostics and clinical pathology to two AI biomarkers used in a clinical test for prostate cancer biopsy specimens. The two algorithms included one algorithm with prognostic performance and a second algorithm predictive for treatment benefit from short-term androgen deprivation therapy (ST-ADT). We assessed analytical accuracy, intra-operator reliability, and inter-operator reliability, and biopsy set completeness reliability on two AI algorithms deployed into a clinical laboratory setting. Analytical accuracy was measured using intraclass correlation coefficient (ICC). Reliability studies were assessed using ICC for the prognostic algorithm and percent agreement for the ST-ADT classification algorithm.

Results

Analytical accuracy ICC was 0.991 and 0.934 for the prognostic and ST-ADT algorithms, respectively. Intra-operator reliability was 0.981 (ICC) and 100% (percent agreement) for the prognostic and ST-ADT algorithms, respectively. Inter-operator reliability was 0.994 (ICC) and 93.3% (percent agreement) for the prognostic and ST-ADT algorithms, respectively. Biopsy-completeness reliability for one versus three prostate biopsy cores was 0.894 (ICC) and 91.67% (percent agreement) for the prognostic and ST-ADT algorithms respectively. For one versus six cores, reliability was 0.857 (ICC) and 95.00% (percent agreement) for the prognostic and ST-ADT algorithms respectively.

Conclusion

This study describes a novel approach to AV of AI algorithms in prostate cancer and applies this approach to two algorithms translated for use as a clinical grade AI-based laboratory test, supporting analytical validity of the test.

Zitieren

APA

Gerrard, P., Zhang, J., Yamashita, R., Huang, H., Nag, S., Nhek, S., Kish, J., Cole, A., Silberman, N., Royce, T. J., & Showalter, T. (2024). Analytical Validation of a Clinical Grade Prognostic and Classification Artificial Intelligence Laboratory Test for Men with Prostate Cancer. AI in Precision Oncology. https://doi.org/10.1089/aipo.2024.0004

Vancouver

Gerrard P, Zhang J, Yamashita R, Huang H, Nag S, Nhek S, et al. Analytical Validation of a Clinical Grade Prognostic and Classification Artificial Intelligence Laboratory Test for Men with Prostate Cancer. AI in Precision Oncology. 2024. doi:10.1089/aipo.2024.0004

BibTeX
@article{Gerrard2024,
  author = {Gerrard, Paul and Zhang, Jingbin and Yamashita, Rikiya and Huang, Huei-Chung and Nag, Sanghita and Nhek, Sokha and Kish, Joshua and Cole, Adam and Silberman, Nathan and Royce, Trevor J. and Showalter, Tim},
  title = {Analytical Validation of a Clinical Grade Prognostic and Classification Artificial Intelligence Laboratory Test for Men with Prostate Cancer},
  journal = {AI in Precision Oncology},
  year = {2024},
  doi = {10.1089/aipo.2024.0004}
}
Kostenlos starten →